270 related articles for article (PubMed ID: 26739620)
1. Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer.
Lapshyn H; Bronsert P; Bolm L; Werner M; Hopt UT; Makowiec F; Wittel UA; Keck T; Wellner UF; Bausch D
Langenbecks Arch Surg; 2016 Feb; 401(1):63-9. PubMed ID: 26739620
[TBL] [Abstract][Full Text] [Related]
2. Histopathological tumor invasion of the mesenterico-portal vein is characterized by aggressive biology and stromal fibroblast activation.
Lapshyn H; Bolm L; Kohler I; Werner M; Billmann FG; Bausch D; Hopt UT; Makowiec F; Wittel UA; Keck T; Bronsert P; Wellner UF
HPB (Oxford); 2017 Jan; 19(1):67-74. PubMed ID: 27825542
[TBL] [Abstract][Full Text] [Related]
3. Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma.
Lapshyn H; Schulte T; Sondermann S; May K; Petrova E; Honselmann KC; Braun R; Zemskov S; Keck T; Wellner UF; Bausch D; Bolm L
Pancreatology; 2021 Jan; 21(1):155-162. PubMed ID: 33309623
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
[TBL] [Abstract][Full Text] [Related]
5. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
[TBL] [Abstract][Full Text] [Related]
7. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.
Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089
[TBL] [Abstract][Full Text] [Related]
8. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.
Riediger H; Makowiec F; Fischer E; Adam U; Hopt UT
J Gastrointest Surg; 2006; 10(8):1106-15. PubMed ID: 16966029
[TBL] [Abstract][Full Text] [Related]
9. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
[TBL] [Abstract][Full Text] [Related]
10. Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion.
Oba A; Ito H; Ono Y; Sato T; Mise Y; Inoue Y; Takahashi Y; Saiura A
BJS Open; 2020 Jun; 4(3):438-448. PubMed ID: 32191395
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Outcomes of Tangential
Lapshyn H; Schulte T; Petruch N; Petrova E; Honselmann K; Deichmann S; Braun R; Kulemann B; Hoeppner J; Rades D; Keck T; Wellner UF; Bausch D; Bolm L
Anticancer Res; 2021 Oct; 41(10):5123-5130. PubMed ID: 34593463
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy.
Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N
Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914
[TBL] [Abstract][Full Text] [Related]
13. Significance of pathological positive superior mesenteric/portal venous invasion in pancreatic cancer.
Tewari M
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):572-578. PubMed ID: 27919845
[TBL] [Abstract][Full Text] [Related]
14. Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.
Roch AM; House MG; Cioffi J; Ceppa EP; Zyromski NJ; Nakeeb A; Schmidt CM
J Gastrointest Surg; 2016 Mar; 20(3):479-87; discussion 487. PubMed ID: 26768008
[TBL] [Abstract][Full Text] [Related]
15. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
[TBL] [Abstract][Full Text] [Related]
16. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
[TBL] [Abstract][Full Text] [Related]
17. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
[TBL] [Abstract][Full Text] [Related]
18. Comparison of end-to-end anastomosis and interposition graft during pancreatoduodenectomy with portal vein reconstruction for pancreatic ductal adenocarcinoma.
Terasaki F; Fukami Y; Maeda A; Takayama Y; Takahashi T; Uji M; Kaneoka Y
Langenbecks Arch Surg; 2019 Mar; 404(2):191-201. PubMed ID: 30631907
[TBL] [Abstract][Full Text] [Related]
19. Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection.
Kleive D; Labori KJ; Line PD; Gladhaug IP; Verbeke CS
HPB (Oxford); 2020 Jan; 22(1):50-57. PubMed ID: 31186199
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
